Skip to Main Content

Paper Details

Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.
Cancer Cell
56
2022
IFN, JAK3, PSMB8, T cells, TMB, advanced cutaneous melanoma, anti-CTLA-4, anti-PD-1, genome, immune cell infiltrates, melanoma, methylome, patients, programmed death ligand, transcriptome, tumor, tumors
Author NameAffiliation
Katia NonesQIMR Berghofer Medical Research Institute
Katia NonesQIMR Berghofer Medical Research Institute
John V PearsonQIMR Berghofer Medical Research Institute
John V PearsonQIMR Berghofer Medical Research Institute
Nicholas K HaywardQIMR Berghofer Medical Research Institute
Nicholas K HaywardQIMR Berghofer Medical Research Institute
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred Hospital and NSW Health Pathology
Nicola WaddellQIMR Berghofer Medical Research Institute, The University of Queensland
Nicola WaddellQIMR Berghofer Medical Research Institute, The University of Queensland
Georgina V LongMelanoma Institute Australia, The University of Sydney, Royal North Shore Hospital, Australia Mater Hospital
  • 1 - 10

Datasets

Release 1.2